Sponsor

St. Olavs Hospital HF

Norway Prinsesse Kristinas G. 3, 7030 Trondheim, Norway

About the sponsor

Research activity includes chronic cluster headache, episodic cluster headache, chronic migraine, and episodic migraine, with interest in preventive and symptom-targeted treatment approaches.

Cluster headache
Migraine prophylaxis
Neurovascular pain disorders

The portfolio also reflects work on treatment-resistant headache syndromes and intervention strategies aimed at reducing attack frequency and disability.

About Specializations

St. Olavs Hospital HF runs clinical trials in conditions such as Migraine, Cluster headache, Type 1 diabetes mellitus, Testicular seminoma (pure) stage I, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

17 clinical trials

Testicular seminoma (pure) stage I

Recruiting

Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

Registered drugNo placebo

Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

Registered drugNo placebo

Norway

Participants:18–64 years
Substances:Bleomycin
Sponsor:St. Olavs Hospital HF

Contact Research Centre

Wheezing+1

Recruiting

Study on Betamethasone Sodium Phosphate to Prevent Asthma in Children with First-time Rhinovirus-induced Wheezing

Registered drug

Study on Betamethasone Sodium Phosphate to Prevent Asthma in Children with First-time Rhinovirus-induced Wheezing

Registered drug

Finland

Participants:0–17 years
Substances:Betamethasone Sodium Phosphate
Sponsor:St. Olavs Hospital HF

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Study comparing oxaliplatin and irinotecan chemotherapy effectiveness using tumor testing in patients with metastatic colorectal cancer

Registered drugNo placebo

Study comparing oxaliplatin and irinotecan chemotherapy effectiveness using tumor testing in patients with metastatic colorectal cancer

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Oxaliplatin
Sponsor:St. Olavs Hospital HF

Contact Research Centre

Post procedural complication

Recruiting

Study of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients

Registered drug

Study of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:St. Olavs Hospital HF

Contact Research Centre

Migraine

Recruiting

Study on Atorvastatin for Preventing Episodic Migraine in Adults

Registered drugNo placebo

Study on Atorvastatin for Preventing Episodic Migraine in Adults

Registered drugNo placebo

Norway

Participants:18–64 years
Substances:Atorvastatin
Sponsor:St. Olavs Hospital HF

Contact Research Centre

Migraine

Recruiting

Study on Atorvastatin for Preventing Chronic Migraine in Adults

Registered drugNo placebo

Study on Atorvastatin for Preventing Chronic Migraine in Adults

Registered drugNo placebo

Norway

Participants:18–64 years
Substances:Atorvastatin
Sponsor:St. Olavs Hospital HF

Contact Research Centre

Retinopathy of prematurity

Not yet recruiting

Intranasal Dexmedetomidine for Pain Relief During Retinopathy of Prematurity Screening in Preterm Infants <30 Weeks Gestation Using Standard Drug Combination

Registered drug